NEW YORK (GenomeWeb) – Cynvenio Biosysterms and Color announced an agreement today to offer a combined version of their respective liquid biopsy and hereditary cancer tests.

Using the new offering, clinicians can test breast cancer patients for alterations in the 30 genes on Color's hereditary cancer panel, as well as for somatic cancer mutations in the 27 genes that Cynvenio's ClearID breast cancer test covers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Feb
27

In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep. 

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.